Medtronic plc
$93.35
The Read: Medtronic’s stock has historically declined on earnings beats due to margin contraction and tariff headwinds, but rallied sharply on regulatory wins, product expansions, and strategic acquisitions like SPR Therapeutics that boosted investor confidence.
MDT
Hover to view data
No Data